Abstract Background Prostate-Specific Membrane Antigen (PSMA) PET/CT and
multiparametric MRI (mpMRI) are well-established modalities for identifying intra-prostatic …

Background: Early prostate cancer diagnosis from BP-MRI studies constitutes the new
guidelines in PI-RADS-2 protocol. From such sequences, malignant lesions are …

Background: Multiparametric Magnetic Resonance Imaging (mpMRI)-based targeted biopsy
has shown to be beneficial in detecting Clinically Significant Prostate Cancer (csPCa) and …

Objective This study aimed to develop a novel nomogram to predict clinically significant
prostate cancer in patients undergoing multi-parametric prostate MRI-assisted lesion …

Aim To investigate the predictive value of lesion length in multiparametric prostate MRI with
respect to prostate volume for clinically significant prostate cancer diagnosis in targeted …

Abstract Purpose Prostate Imaging-Reporting and Data System (PI-RADS) assists in
evaluating lesions on multiparametric magnetic resonance imaging (mpMRI), but there are …

To investigate the relationship between lesion size determined using multiparametric
magnetic resonance imaging (mpMRI) and histopathological findings of specimens obtained …

Objective: To evaluate the demographics, preoperative or pathological factors, and findings
of magnetic resonance imaging (MRI) to predict the factors affecting biochemical recurrence …

Objectives: To determine the factors that predict the failure of systematic prostate biopsy by
examining the clinical, laboratory, and radiological parameters of patients for whom prostate …

Objective: This study aims to compare the clinically significant prostate cancer (csPCa)
detection rates of cognitive targeted biopsy (CTB) and systematic biopsy (SB) and to reveal …